As with any disease, there is variability in the clinical signs and the eventual outcome of the infection. (lowchensaustralia.com)
The researchers showed that a two - day treatment regimen with partial or selective PPAR - γ agonists (Telmisartan and Rosiglitazone — both FDA - approved drugs) ameliorated the pathological outcomes of infection in mice by inducing expression of glucose transporters. (sciencedaily.com)
«We can count changes in numbers of bacteria, but if that doesn't change the outcome of the infection — change the number of [animals] that die — it's not worth it.» (sciencenews.org)